These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 26216673

  • 21. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM.
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [Abstract] [Full Text] [Related]

  • 22. Percutaneous cryoablation of renal masses: Washington University experience of treating 129 tumours.
    Kim EH, Tanagho YS, Bhayani SB, Saad NE, Benway BM, Figenshau RS.
    BJU Int; 2013 May; 111(6):872-9. PubMed ID: 23145500
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ, Cookson MS, Chapman W, Harrell F, Wells N, Chang SS, Smith JA.
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Renal cell carcinoma in dialysis patients: a single center experience.
    Kojima Y, Takahara S, Miyake O, Nonomura N, Morimoto A, Mori H.
    Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients.
    Fujii Y, Komai Y, Saito K, Iimura Y, Yonese J, Kawakami S, Ishikawa Y, Kumagai J, Kihara K, Fukui I.
    Urology; 2008 Sep; 72(3):598-602. PubMed ID: 18649929
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J, Thiel DD, Lohse CM, Williams A, Arnold ML, Cheville JC, Leibovich BC, Parker AS.
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [Abstract] [Full Text] [Related]

  • 35. Population-based comparative effectiveness of nephron-sparing surgery vs ablation for small renal masses.
    Whitson JM, Harris CR, Meng MV.
    BJU Int; 2012 Nov; 110(10):1438-43; discussion 1443. PubMed ID: 22639860
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Use of surveillance imaging following treatment of small renal masses.
    Kowalczyk KJ, Harbin AC, Choueiri TK, Hevelone ND, Lipsitz SR, Trinh QD, Tina Shih YC, Hu JC.
    J Urol; 2013 Nov; 190(5):1680-5. PubMed ID: 23764074
    [Abstract] [Full Text] [Related]

  • 38. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N, Cranston D, Akhtar MZ, George C, Jones A, Leiblich A, Protheroe A, Sullivan M.
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [Abstract] [Full Text] [Related]

  • 39. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results.
    Yu J, Liang P, Yu XL, Cheng ZG, Han ZY, Zhang X, Dong J, Mu MJ, Li X, Wang XH.
    Radiology; 2014 Mar; 270(3):880-7. PubMed ID: 24475805
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.